Benign and malignant neoplasias in 261 necropsies for HIV-positive patients in the period of 1989 to 2008

• Published in: Revista do Instituto de Medicina Tropical de São Paulo
• Main Authors: Adilha Rua Micheletti, Ana Carolina Sandoval Macedo, Gisele Barbosa e Silva, Ana Cristina Araújo Lemos da Silva, Mário Leon Silva-Vergara, Eddie Fernando Cândido Murta, Sheila Jorge Adad
• Format: Article in Journal/Newspaper
• Language: English
• Published: Universidade de São Paulo (USP) 2011
• Subjects: HIV; AIDS; Neoplasm benign; Neoplasm malignant; Necropsy; Arctic medicine. Tropical medicine; RC955-962; Infectious and parasitic diseases; RC109-216; Arctic
• Online Access: https://doi.org/10.1590/S0036-46652011000600002; https://doaj.org/article/6545853469774c0c9390d0fbfee82c53

Considering that there are some studies with autopsies from AIDS describing only malignant neoplasias and that changes can occur after the introduction of Highly Active Antiretroviral Therapy (HAART), our objectives were to analyze the frequency of benign and malignant neoplasms in AIDS patients in the periods of both pre- and post-HAART. This is a retrospective study with 261 autopsies of HIV-positive patients between 1989 and 2008 in Uberaba, Brazil. Sixty-six neoplasms were found (39 benign, 21 malignant and six premalignant) in 58 patients. The most frequent malignant neoplasms were lymphoid, in 2.7% (four Non-Hodgkin lymphoma, one Hodgkin, one multiple myeloma and one plasmablastic plasmacytoma), and Kaposi's Sarcoma, in 2.3% (six cases). The most frequent benign neoplasms were hepatic hemangiomas in 11 (4.2%) of 261 cases and uterine leiomyoma in 11 (15.7%) of 70 woman. In the pre-HAART period eight (9.8%) benign neoplasias and four (4.9%) malignant occurred in 82 patients; in the post-HAART period, 29 (16.2%) benign and 17 (9.5%) malignant were present; however, the differences were not significant. We conclude that the introduction of HAART in our region doesn't look to have modified the frequency of neoplasms occurring in patients with HIV.